Keywords: merck, co, emend, cleared, fda, nausea, cancer

Merck & Co's Emend cleared by FDA for nausea in cancer chemotherapy

Article | 07 April 2003

Print This

Merck & Co has been granted approval by the US Food and DrugAdministration for Emend (aprepitant), its new drug for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in